Fig. 2From: The prognostic value of weight loss during radiotherapy among patients with nasopharyngeal carcinoma: a large-scale cohort studyComparison between the RT-PWL7 < 5% group and the RT-PWL7 ≥ 5% group for A disease-free survival, B overall survival, C distant metastasis-free survival, and D locoregional relapse-free survival. RT-PWL7, percentage of weight loss at week 7 of radiotherapy (RT)Back to article page